| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.096 | 0.09 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |